![A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents | 2 Minute Medicine A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents | 2 Minute Medicine](https://www.2minutemedicine.com/wp-content/uploads/2017/01/Psoriasis_cc_edited_wiki_James-Heilman-MD.jpg)
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents | 2 Minute Medicine
![Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs | The Journal of Rheumatology Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/39/8/1559/F2.large.jpg)
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs | The Journal of Rheumatology
![1610758-20-7 | O-(2-Ethylbutyl) Dabigatran Ethyl Ester | N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine Ethyl Ester; Dabigatran Impurity C | C₃₇H₃₈N₇O₅ | TRC 1610758-20-7 | O-(2-Ethylbutyl) Dabigatran Ethyl Ester | N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine Ethyl Ester; Dabigatran Impurity C | C₃₇H₃₈N₇O₅ | TRC](https://www.trc-canada.com/prod-img/E900655.png)
1610758-20-7 | O-(2-Ethylbutyl) Dabigatran Ethyl Ester | N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine Ethyl Ester; Dabigatran Impurity C | C₃₇H₃₈N₇O₅ | TRC
![51865-79-3 | (R)-Methotrexate | D-Amethopterin; D-Methotrexate; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-D-glutamic Acid; | C₂₀H₂₂N₈O₅ | TRC 51865-79-3 | (R)-Methotrexate | D-Amethopterin; D-Methotrexate; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-D-glutamic Acid; | C₂₀H₂₂N₈O₅ | TRC](https://www.trc-canada.com/prod-img/M260665.png)
51865-79-3 | (R)-Methotrexate | D-Amethopterin; D-Methotrexate; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-D-glutamic Acid; | C₂₀H₂₂N₈O₅ | TRC
![71074-44-7 | Methotrexate Dimethylamide (>90%) | N2-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-N,N-dimethyl-L-glutamine; NSC 281286 | C₂₂H₂₇N₉O₄ | TRC 71074-44-7 | Methotrexate Dimethylamide (>90%) | N2-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-N,N-dimethyl-L-glutamine; NSC 281286 | C₂₂H₂₇N₉O₄ | TRC](https://www.trc-canada.com/prod-img/M260695.png)